PIK3CA and neoplasm: To sum up, more trials are needed to explore the combinations of PI3K/AKT/mTOR signaling pathways in the future, in addition, how to exert the role of negative regulatory factors in the pathway to achieve anti-tumor effects is also a potential research direction.